| SAREUM HLDGS LS-,0125 |
| Großbritannien |
| Gesundheit |
| GB00BMC3RJ87 / A3DWCH |
| RYH0 (Frankfurt) |
| FRA:RYH0, ETR:RYH0, RYH0:GR |
| - |
| https://sareum.com/ |
|
Sareum Holdings plc is a biotechnology company focused on the discovery and development of innovative cancer therapeutics. The primary purpose of Sareum Holdings is to utilize its expertise in medical research to develop small molecule therapeutics, ..
>Volltext.. |
| 24.51 Mio. EUR |
| 21.66 Mio. EUR |
| - |
| -4.5 Mio. EUR |
| -5.75 Mio. EUR |
| -0.04 EUR |
| - |
| 2.9 Mio. EUR |
| -3.8 Mio. EUR |
| 1.22 |
| - |
| -125.78% |
| - |
| - |
| - |
| - |
| SAREUM |
| 05.04.26 |
|